Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments

This study examines the strength of association between surrogate markers used as primary end points in clinical trials to support FDA approval of drugs treating nononcologic chronic diseases and clinical outcomes.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research